365 industry insights, trends, best practices & benchmarking

RNA Therapeutics Investments – Global Funding Outlook of the Evolving State of RNA Medicines and Technologies

🗓️ Tuesday 25th June 2024
⏲ 11:30 am EST

Navigating the Evolving Pharma M&A Landscape: Trends, Challenges, and Opportunities

🗓️ September 2024
⏲ 10:00 am EST

AI-Powered Insights: Revolutionizing Pharma BD Deals

🗓️ Tuesday 11th June 2024
⏲ 2:00 PM BST

Evaluation of current and advanced analytical technologies for the comprehensive characterization of mRNA and its impurities

🗓️ Wednesday 17th April 2024
⏲ 4:30 PM CET

Capital Markets & Deal-Making 2024 Expectations: A Beaming Horizon of Opportunity, Innovation, Investments, and Partnerships

🗓️ Tuesday 20th February 2024
⏲ 2:00 PM GMT

Reverse Mergers: Planning and Executing a Path to Public Capital

🗓️ Thursday 30th November 2023
⏲ 3:00 PM GMT

Unlocking the Future: The Growing Significance of AI in Biopharma and BD&L 

🗓️ Wednesday 25th October 2023
⏲ 3:00 PM BST

Planning for Cell & Gene Therapy Commercialization

🗓️ Wednesday 18thh October 2023
⏲ 3:00 PM BST